Related Experiment Video
Updated: Apr 26, 2026
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Synthesis and evaluation of novel podophyllotoxin derivatives as potential antitumor agents
Wei-Hua Cheng1, Bo Cao2, Hai Shang1
1Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, PR China.
Abstract:
Cancer multidrug resistance (MDR) is a common cause of treatment failure in cancer patients. Increased expression of permeability glycoprotein (P-gp), which is also known as MDR-1, is the main cause of multidrug resistance. Podophyllotoxin derivatives hold great promise in the battle to overcome multidrug resistance, as they can induce cytotoxicity through multiple mechanisms. Here, we synthesized sixteen novel podophyllotoxin derivatives and evaluated their cytotoxicities in human cancer cell lines, HeLa, K562 and K562/A02. Some of these compounds were more potent than etoposide, a clinically relevant inhibitor of DNA repair enzymes. In particular, compound 5p exhibited the most potent activity toward drug-resistant K562/A02 cells, as it robustly inhibited tumor cell proliferation and induced apoptosis. Furthermore, preliminary investigation suggested that 5p inhibited the expression of MDR-1 in K562/A02 cells more effectively than etoposide.
Insights
Novel podophyllotoxin derivatives show promise in overcoming cancer multidrug resistance (MDR). Compound 5p effectively inhibited drug-resistant cancer cell proliferation and MDR-1 expression, offering a potential new strategy against treatment failure.
Area of Science:
- Medicinal Chemistry
- Cancer Biology
- Pharmacology
Background:
- Cancer multidrug resistance (MDR) is a major obstacle in effective cancer chemotherapy.
- Increased expression of P-glycoprotein (P-gp), also known as MDR-1, is a primary driver of MDR.
- Podophyllotoxin derivatives are investigated for their potential to overcome MDR via multiple cytotoxic mechanisms.
Purpose of the Study:
- To synthesize and evaluate novel podophyllotoxin derivatives for their anticancer and MDR-reversing activities.
- To identify potent compounds against drug-resistant cancer cell lines.
- To investigate the mechanism of action, focusing on MDR-1 inhibition.
Main Methods:
- Synthesis of sixteen novel podophyllotoxin derivatives.
- Evaluation of cytotoxicity against human cancer cell lines (HeLa, K562, K562/A02).
- Comparison of compound efficacy with etoposide, a DNA repair inhibitor.
- Preliminary investigation of MDR-1 expression inhibition.
Main Results:
- Several synthesized derivatives demonstrated significant cytotoxic activity.
- Compound 5p exhibited superior potency against drug-resistant K562/A02 cells compared to etoposide.
- Compound 5p effectively inhibited tumor cell proliferation and induced apoptosis.
- Preliminary data indicate compound 5p is a more effective inhibitor of MDR-1 expression than etoposide.
Conclusions:
- Novel podophyllotoxin derivatives possess potent anticancer and MDR-inhibiting properties.
- Compound 5p is a promising candidate for overcoming P-gp-mediated multidrug resistance.
- Further research into compound 5p could lead to novel therapeutic strategies for resistant cancers.
More Related Videos
08:47Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
Published on: March 6, 2019
13:17In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023
